Explore
MicroRNA in Solid Tumor and Hematological Diseases
0 Ungluers have
Faved this Work
Login to Fave
MicroRNAs (miRNAs), which are a type of short non-coding RNA, are involved in number of processes, such as differentiation, development, inflammation, immune response, and cancer. miRNAs, which act as oncogenes or tumor suppressor genes, can control and regulate the translation and stability of target messenger RNA, contributing to cancer pathogenesis. Despite the progress that has been made in discovering the mechanisms of how miRNAs function in tumors, many questions and aspects of miRNA biology and processing still remain to be determined. This Special Issue, titled “MicroRNA in Solid Tumor and Hematological Diseases”, provides a panorama of the existing knowledge gaps and potential uses of microRNAs to predict clinical outcome or response to therapies and provides evidence to explain their role as biomarkers to modulate the biological pathways that are critical for cancer development and progression. It includes eleven peer-reviewed papers that cover the role of microRNAs in different tumor types and their potential applications in diagnosis and clinical approaches.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 53 times via unglue.it ebook links.
- 53 - pdf (CC BY) at Unglue.it.
Keywords
- acute lymphoblastic leukemia
- acute myeloblastic leukemia
- amino acid transporters
- ASCT2
- Bladder cancer
- cancer cell
- cancer therapy
- chemotherapy
- circulating miRNAs
- colorectal cancer
- Diagnosis
- drug resistance
- drug response
- epithelial ovarian cancer
- expression profiling
- follicular lymphoma
- Gene expression
- GI cancers
- hairy cell leukemia
- hepatocellular carcinoma
- Hippo kinase
- LAT1
- Liquid Biopsy
- Liver disease
- marginal zone lymphoma
- microRNA
- MicroRNAs
- miR-139-3p
- miR-139-5p
- miR-7
- miRNA
- miRNAs
- n/a
- normal B-cell development
- normalizer
- ovarian cancer
- paxillin (PXN)
- PDAC
- personalized medicine
- post-transcriptional regulation
- primary cutaneous follicle center lymphoma
- prognosis
- reference miRNA
- Reference, information & interdisciplinary subjects
- Renal cell carcinoma (RCC)
- Research & information: general
- RT-qPCR
- solid cancer
- Survival
- targeted therapy
- Therapeutic target
- tumor suppressor
- urine
- Waldenström’s macroglobulinemia
- Yes-associated protein
Links
DOI: 10.3390/books978-3-0365-3089-5Editions